Back to search
Peritoneal Dialysis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Peritoneal Dialysis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Peritoneal Dialysis trials you may qualify forChronic kidney disease affects a significant portion of the UK population, with approximately 3.5 million adults diagnosed. At its most severe stage, end-stage…
The primary aim of this study is to determine the safety and mechanisms of SGLT2 inhibition in individuals on peritoneal dialysis (PD) with residual kidney func…
Within few years the peritoneal membrane of adult peritoneal dialysis (PD) patients undergoes substantial morphological transformation, including progressive fi…
The goal of this clinical trial is to learn if this intervention (the CHOOSE Home intervention) is feasible and may lead to more home dialysis usage in a high-r…
The aim of this observational study is to determine if and how kidney failure affects the development of protective immune responses following vaccination in pa…
This project aims to examine the effects of six-month treatment with selective SGLT2 inhibitor dapagliflozin in patients with end-stage kidney disease on chroni…
The study aims to examine the use of hydrocolloid dressing for catheter exit-site care in peritoneal dialysis patients. It is a pilot study, and participants wi…
Sodium accumulates in the tissues of patients with kidney disease and impairs survival. Three-times weekly, standard hemodialysis alone cannot remove excess sod…